Association between <i>CYP3A5</i> Polymorphism and Statin-Induced Adverse Events: A Systemic Review and Meta-Analysis
<b>Purpose:</b> Cytochrome P450 (CYP) is involved in the metabolism of statins; CYP3A5 is the main enzyme responsible for lipophilic statin metabolism. However, the evidence of the association between <i>CYP3A5*3</i> polymorphism and the risk of statin-induced adverse events...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/7/677 |